These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 15526008

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Long-term intracavernous therapy responders can potentially switch to sildenafil citrate after radical prostatectomy.
    Raina R, Lakin MM, Agarwal A, Ausmundson S, Montague DK, Zippe CD.
    Urology; 2004 Mar; 63(3):532-7; discussion 538. PubMed ID: 15028452
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and factors associated with successful outcome of sildenafil citrate use for erectile dysfunction after radical prostatectomy.
    Raina R, Lakin MM, Agarwal A, Mascha E, Montague DK, Klein E, Zippe CD.
    Urology; 2004 May; 63(5):960-6. PubMed ID: 15134989
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Intraurethrally applicated alprostadil for the treatment of organic erectile dysfunction in practice: a multicenter clinical monitoring study (noninterventional investigation)].
    Potempal AJ, Potempa DM, Görlich HD, Stolpmann RM.
    Arzneimittelforschung; 2007 May; 57(6):299-308. PubMed ID: 17688074
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Rationale for combination therapy of intraurethral prostaglandin E(1) and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy.
    Nehra A, Blute ML, Barrett DM, Moreland RB.
    Int J Impot Res; 2002 Feb; 14 Suppl 1():S38-42. PubMed ID: 11850734
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Acceptance of and discontinuation rate from erectile dysfunction oral treatment in patients following bilateral nerve-sparing radical prostatectomy.
    Salonia A, Gallina A, Zanni G, Briganti A, Dehò F, Saccà A, Suardi N, Barbieri L, Guazzoni G, Rigatti P, Montorsi F.
    Eur Urol; 2008 Mar; 53(3):564-70. PubMed ID: 17761385
    [Abstract] [Full Text] [Related]

  • 14. A prospective evaluation of efficacy and compliance with a multistep treatment approach for erectile dysfunction in patients after non-nerve sparing radical prostatectomy.
    Gontero P, Fontana F, Zitella A, Montorsi F, Frea B.
    BJU Int; 2005 Feb; 95(3):359-65. PubMed ID: 15679794
    [Abstract] [Full Text] [Related]

  • 15. Sexual function after male radical cystectomy in a sexually active population.
    Zippe CD, Raina R, Massanyi EZ, Agarwal A, Jones JS, Ulchaker J, Klein EA.
    Urology; 2004 Oct; 64(4):682-5; discussion 685-6. PubMed ID: 15491700
    [Abstract] [Full Text] [Related]

  • 16. Use of combined intracorporal injection and a phosphodiesterase-5 inhibitor therapy for men with a suboptimal response to sildenafil and/or vardenafil monotherapy after radical retropubic prostatectomy.
    Mydlo JH, Viterbo R, Crispen P.
    BJU Int; 2005 Apr; 95(6):843-6. PubMed ID: 15794795
    [Abstract] [Full Text] [Related]

  • 17. Sildenafil citrate and vacuum constriction device combination enhances sexual satisfaction in erectile dysfunction after radical prostatectomy.
    Raina R, Agarwal A, Allamaneni SS, Lakin MM, Zippe CD.
    Urology; 2005 Feb; 65(2):360-4. PubMed ID: 15708053
    [Abstract] [Full Text] [Related]

  • 18. Erectile dysfunction following nerve-sparing radical retropubic prostatectomy and its treatment with sildenafil.
    Shimizu T, Hisasue S, Sato Y, Kato R, Kobayashi K, Tsukamoto T.
    Int J Urol; 2005 Jun; 12(6):552-7. PubMed ID: 15985077
    [Abstract] [Full Text] [Related]

  • 19. Use of intraurethral alprostadil in patients not responding to sildenafil citrate.
    Jaffe JS, Antell MR, Greenstein M, Ginsberg PC, Mydlo JH, Harkaway RC.
    Urology; 2004 May; 63(5):951-4. PubMed ID: 15134987
    [Abstract] [Full Text] [Related]

  • 20. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
    Eardley I, Montorsi F, Jackson G, Mirone V, Chan ML, Loughney K, Vail GM, Beardsworth A.
    BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.